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Cell-based therapies involving the delivery of adipose-derived stromal cells (ASCs)
on decellularized adipose tissue (DAT) scaffolds are a promising approach for soft
tissue augmentation and reconstruction. Our lab has recently shown that culturing
human ASCs on DAT scaffolds within a perfusion bioreactor prior to implantation can
enhance their capacity to stimulate in vivo adipose tissue regeneration. Building from this
previous work, the current study investigated the effects of bioreactor preconditioning
on the ASC phenotype and secretory profile in vitro, as well as host cell recruitment
following implantation in an athymic nude mouse model. Immunohistochemical analyses
indicated that culturing within the bioreactor increased the percentage of ASCs coexpressing inducible nitric oxide synthase (iNOS) and arginase-1 (Arg-1), as well as
tumor necrosis factor-alpha (TNF-α) and interleukin-10 (IL-10), within the peripheral
regions of the DAT relative to statically cultured controls. In addition, bioreactor culture
altered the expression levels of a range of immunomodulatory factors in the ASC-seeded
DAT. In vivo testing revealed that culturing the ASCs on the DAT within the perfusion
bioreactor prior to implantation enhanced the infiltration of host CD31+ endothelial
cells and CD26+ cells into the DAT implants, but did not alter CD45+ F4/80+ CD68+
macrophage recruitment. However, a higher fraction of the CD45+ cell population
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expressed the pro-regenerative macrophage marker CD163 in the bioreactor group,
which may have contributed to enhanced remodeling of the scaffolds into hostderived adipose tissue. Overall, the findings support that bioreactor preconditioning
can augment the capacity of human ASCs to stimulate regeneration through paracrinemediated mechanisms.
Keywords: bioreactors, decellularized adipose tissue, preconditioning, angiogenesis, immunomodulation,
macrophage, adipose-derived stromal cell

stimulate regeneration. To address this limitation, we recently
investigated the effects of culturing human ASCs on the 3D DAT scaffolds used for cell delivery within a scaffold-based
perfusion bioreactor system (Han and Flynn, 2020). Our findings
demonstrated that dynamic culture under 2% O2 promoted
human ASC expansion in the peripheral regions of the DAT.
Further, culturing within the bioreactor under 2% O2 for
14 days prior to implantation significantly augmented blood
vessel infiltration and host-derived adipose tissue formation
within the DAT scaffolds in a subcutaneous implant model in
athymic nude (nu/nu) mice in comparison to scaffolds cultured
within the bioreactor under 20% O2 , as well as statically cultured,
freshly seeded, and unseeded controls (Han and Flynn, 2020).
While the restrictions on the implant size and differences in
the structure of the skin make it challenging to translate the
findings of mouse models to predict future outcomes in humans,
in vivo studies in immunocompromised mice remain a valuable
tool for characterizing the effects of human ASCs in a complex
physiological environment and for comparing the efficacy of
varying ASC culture strategies or delivery platforms.
Although the delivery of a higher density of ASCs within
the DAT scaffolds likely contributed to the enhanced adipose
tissue regeneration observed in the 2% O2 bioreactor group, the
dynamic culture conditions may have also preconditioned the
ASCs to have a more pro-regenerative phenotype. A growing
body of evidence supports that ASCs delivered within scaffolds
primarily stimulate regeneration through transient paracrinemediated effects, rather than through long-term engraftment and
differentiation (Chazenbalk et al., 2011; Suga et al., 2014; Kang
et al., 2014). More specifically, ASCs can secrete a diverse range
of growth factors and cytokines that can promote the recruitment
and/or modulate the response of host cells, including endothelial
cells, adipogenic progenitors, and immune cell populations that
can contribute to implant remodeling and de novo adipose tissue
formation (Kapur and Katz, 2013). While the stimulatory effects
of hypoxia on pro-angiogenic factor and cytokine secretion are
well documented (Thangarajah et al., 2009; Hsiao et al., 2013), the
effects of dynamic culture on MSC paracrine factor expression
remain largely unexplored, with most bioreactor studies to date
focused on characterizing the effects on proliferation and/or
differentiation (Zhao and Ma, 2005; Alvarez-Barreto et al., 2011;
Dos Santos et al., 2014; Yu et al., 2017).
Recognizing that dynamic culture may enhance the proregenerative capacity of the ASCs, we hypothesized that culturing
the ASCs on the DAT scaffolds within the perfusion bioreactor
would modulate their phenotype and paracrine function.
Building from our previous work, human ASCs were cultured on

INTRODUCTION
Tissue-engineering strategies represent a promising approach for
the long-term augmentation and regeneration of damaged or
deficient subcutaneous adipose tissue for applications in plastic
and reconstructive surgery. Recent advancements in the field
have focused on using a combined approach involving cell-seeded
scaffolds as a means to provide both immediate volumetric
augmentation and promote the stable regeneration of hostderived soft tissues (Choi et al., 2009; Brett et al., 2017). In
particular, decellularized adipose tissue (DAT) has emerged as a
promising pro-adipogenic platform for this application (Flynn,
2010; Mohiuddin et al., 2019). DAT scaffolds can be fabricated
from human adipose tissue that is abundantly discarded as
surgical waste, and have been shown to retain biochemical and
biophysical properties that mimic the native tissue source, which
may be favorable for adipose tissue regeneration (Haddad et al.,
2016; Kuljanin et al., 2017).
While applying DAT as an off-the-shelf scaffold is appealing,
studies have suggested that the rate and extent of adipose
tissue regeneration can be enhanced by seeding the scaffolds
with pro-regenerative progenitor cells (Young et al., 2014;
Wang et al., 2013). This strategy may be critical for the larger
volume augmentation that is required for many reconstructive
applications in the clinic, as a lack of angiogenesis and host cell
infiltration can result in implant failure. Previous work from
our lab supports that seeding the DAT with adipose-derived
stromal cells (ASCs) can enhance in vivo angiogenesis and host
adipogenesis in immunocompetent mouse and rat models (Han
et al., 2015; Robb et al., 2020). ASCs are a logical cell source for
this application given their relative abundance and accessibility
(Bourin et al., 2013), their high tolerance of ischemic conditions
such as those immediately following implantation (Suga et al.,
2010), as well as their enhanced adipogenic potential compared
to other mesenchymal stromal cell (MSC) sources (Pizzute et al.,
2015). Most clinical plastic surgery studies to date have focused
on using the stromal vascular fraction (SVF) of adipose tissue to
avoid the translational hurdles associated with the use of cultured
ASC populations. However, through careful consideration of
the cell culture microenvironment, it may be possible to design
systems for cell expansion and preconditioning that would
augment the capacity of the ASCs to stimulate regeneration,
resulting in a more robust and predictable response that would
justify the additional costs and regulatory hurdles involved.
In our previous work, the static seeding methods used resulted
in a sparse and heterogeneous spatial distribution of ASCs on
the DAT scaffolds, which may have restricted their capacity to
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N2 /5% CO2 , 37◦ C) were maintained for all cultures using a tri-gas
incubator (ThermoFisher Forma Series II 3110).

DAT scaffolds under 2% O2 either within the perfusion bioreactor
or statically within the culture inserts for 14 days. In vitro analyses
were first performed to assess the effects of dynamic culturing on
ASC phenotype and paracrine factor expression. Subsequently,
the impact of bioreactor preconditioning on the pro-regenerative
paracrine functionality of the ASC-seeded DAT scaffolds was
explored by characterizing host cell recruitment at 1-, 4-, and
8-weeks post-implantation in the athymic nude mouse model.

Immunohistochemical Assessment of
the Effects of Bioreactor Culture on the
DAT on Phenotypic Markers
Immunohistochemical analyses were performed to assess the
expression of inducible nitric oxide synthase (iNOS), a marker
associated with the immunomodulatory function of murine
MSCs (Ren et al., 2008; Li et al., 2012; Maria et al., 2018), as well as
arginase-1 (Arg-1), in the ASCs within the peripheral (<200 µm
from the scaffold edge) or central (>200 µm from the scaffold
edge) regions of the DAT scaffolds cultured either dynamically or
statically for 14 days. In addition, triple staining was performed
for Arg-1 with the immunomodulatory cytokines interleukin-10
(IL-10) and tumor necrosis factor-α (TNFα). The primary and
secondary antibodies and dilutions are summarized in Table 1.
For both analyses, scaffolds were fixed in 4%
paraformaldehyde for 24 h at 4◦ C before being embedded
in paraffin and sectioned (7 µm sections). The sections were
de-paraffinized in an ethanol series and heat-mediated antigen
retrieval was performed by incubating in Tris-EDTA buffer
(10 mM tris base, 1 mM EDTA, 0.05% Tween-20, pH 9.0) at
95◦ C on a hot plate for 25 min. The sections were cooled for
25 min and then blocked with 5% BSA in PBS-T (0.1% Tween
20) for 1 h at room temperature before being incubated with
the primary antibodies for iNOS in combination with Arg-1 or
Arg-1 in combination with TNF-α and IL-10 at 4◦ C overnight.
Next, the sections were washed with PBS and incubated with the
secondary antibodies for 1 h at room temperature. Mouse spleen
and liver were used as tissue positive controls, and no primary
antibody controls were included in all trials.
Stained cross-sections were mounted in Fluoroshield
Mounting Medium with DAPI (Abcam, Cambridge, MA,
United States) and visualized with an EVOS FL Cell Imaging
System (Thermo Fisher Scientific). Positively stained cells from
five non-overlapping fields of view from both the central and
peripheral regions were quantified manually in a blinded fashion
using ImageJ Software in three non-adjacent cross-sections
taken at least 100 µm apart from each scaffold. For the analyses,
grayscale images for each color channel were used, and a
brightness threshold of 50–255 was applied with a particle
size >50 used to quantify DAPI+ cells. A total of 3 trials were
performed with ASCs from different donors (N = 3).

MATERIALS AND METHODS
Materials
Unless otherwise stated, all reagents were purchased from Sigma
Aldrich Canada Ltd., and used as received (Oakville, Canada).

Human Adipose Tissue Collection and
Processing
Surgically discarded subcutaneous adipose tissue was collected
with informed consent from female donors undergoing elective
lipo-reduction surgeries at the University Hospital or St. Joseph’s
Hospital in London, ON, Canada. Human Research Ethics Board
approval for this study was obtained from Western University
(HSREB# 105426). The fresh tissues were transported to the lab
in sterile phosphate buffered saline (PBS) supplemented with 2%
bovine serum albumin (BSA) on ice. Within 2 h of collection,
the adipose tissue was processed for either ASC isolation or
decellularization following established protocols (Flynn, 2010).
The human ASCs were cultured on T75 flasks (Corning,
Fisher Scientific, Ottawa, Canada) in proliferation medium
(DMEM:Ham F12 (Wisent, St. Bruno, Canada) supplemented
with 10% fetal bovine serum (FBS; Wisent, St. Bruno, Canada)
and 100 U/mL penicillin and 0.1 mg/mL streptomycin (1% penstrep; Thermo Fisher Scientific, Waltham, MA, United States).
To prepare the DAT scaffolds for cell culture, DAT samples
were lyophilized and cut into individual scaffolds having a mass
of 8 ± 1 mg, sized to fit within the cylindrical culture inserts
used for both groups in this study (height 11 mm, inner diameter
5 mm) (Han and Flynn, 2020). The scaffolds were rehydrated
in deionized water, decontaminated through repeated rinsing in
70% ethanol, and washed in sterile PBS. Prior to seeding, the
scaffolds were equilibrated in fresh proliferation medium for 24 h.

R

Scaffold Seeding and Culture
Adipose-derived stromal cells were seeded at passage 3 at
a density of 1 × 106 cells/scaffold as previously described
(Han and Flynn, 2020), transferred into the culture inserts,
and cultured in proliferation medium for 14 days either
statically in 15 mL vented-cap conical tubes or dynamically
within a customized perfusion bioreactor system (Tissue Growth
Technologies, Instron) under a flow rate of 0.5 mL/min (Han and
Flynn, 2020). Both the dynamic and static control samples were
cultured within the cylindrical inserts (Han and Flynn, 2020)
to ensure that the scaffold geometry and the surface area that
was in direct contact with the media prior to perfusion were
consistent between the groups. Hypoxic conditions (2% O2 /93%
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Quantitative Analysis of the Effects of
Perfusion Bioreactor Culture on
Immunomodulatory Factor Expression in
Human ASCs Cultured on the DAT
A Human Magnetic Luminex Assay was performed to compare
the protein expression levels of a range of pro-angiogenic and
immunomodulatory factors between the static and dynamic
groups at 14 days. TNF-α and IL-10 were selected based on
their well-recognized counterbalancing roles in regulating the
inflammatory response, as well as to compare with the IHC
findings. Hepatocyte growth factor (HGF) was chosen as a
R
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TABLE 1 | Primary and secondary antibodies and dilutions used for immunostaining in the in vitro studies.
Primary antibody

Primary Dilution

Secondary antibody

Secondary Dilution

Arg-1 (Millipore ABS535)

1:100

Goat anti-chicken Alexa R 488
(Abcam ab150169)

1:200

iNOS (Abcam ab15323)

1:100

Goat anti-rabbit Alexa R 594
(Abcam ab150080)

1:200

TNF-α (Abcam ab6671)

1:200

Goat anti-rabbit Alexa R 594
(Abcam ab150080)

1:400

IL-10 (R&D AF519)

1:50

Donkey anti-goat Alexa R 680
(ThermoFisher A-21084)

1:100

pleiotropic factor that is highly expressed by ASCs, which
can have both pro-angiogenic and anti-inflammatory effects
(Cai et al., 2007; Ceccarelli et al., 2020). Chemokine C-X-C
motif 10 (CXCL-10) was selected as a marker associated with
inflammation in adipose tissue (Kochumon et al., 2020), as well
as macrophage recruitment in other tissues (Petrovic-Djergovic
et al., 2015). Finally, C-X-C motif ligand 2 (CXCL-2) was
chosen as a pro-inflammatory chemokine that has been shown
to be upregulated during adipogenic differentiation (Kusuyama
et al., 2016; Siebert et al., 2016), and interleukin-6 (IL-6) was
included as an additional pro-inflammatory adipokine that can
modulate both lipid metabolism and macrophage polarization
within adipose tissue (Trujillo et al., 2004; Braune et al., 2017).
For this assay, three replicate scaffolds from each group (n = 3)
were analyzed per ASC donor, and a total of five trials were
performed with different ASC donors (N = 5). In preparation for
the Luminex assay, the individual scaffolds were frozen in liquid
nitrogen, crushed with a mortar and pestle, and resuspended in
a lysis buffer (50 mM Tris-HCl, 100 mM NaCl, 10% glycerol, 1%
Triton X-100, pH 7.4). The samples were then briefly sonicated
with an ultrasonic dismembrator (ThermoFisher Model 100) and
centrifuged at 13,000 × g for 10 min at 4◦ C. The supernatant
from each sample was then analyzed with a Human Magnetic
Luminex Assay (R&D Systems) using a MAGPIX System
(Millipore), in accordance with the manufacturer’s protocols.
Protein concentrations were determined based on comparison
to standard curves and normalized to the double stranded
DNA (dsDNA) content measured in each sample using a
PicoGreen dsDNA Assay (Han and Flynn, 2020), following the
manufacturer’s instructions.

samples were fixed in 4% paraformaldehyde at 4◦ C overnight
before being embedded in paraffin and sectioned (7 µm) for
immunohistochemical analyses.

Subcutaneous Implantation Surgeries

Statistical Methods

In vivo studies were performed to compare the effects of
culturing the ASCs on the DAT scaffolds for 14 days under static
or dynamic conditions on the host cell response. All animal
studies followed Canadian Council on Animal Care (CCAC)
guidelines and the protocols were reviewed and approved by the
Western University Animal Care Committee (Protocol #2015049). Female athymic nude mice (Nu-Foxn1nu ) (Charles River
Laboratories, Sherbrooke, Canada) of 10–13 weeks of age were
used for this study (N = 6 mice per scaffold group/timepoint).
Subcutaneous implantation surgeries were performed following
established protocols (Han and Flynn, 2020). At 1, 4, and
8 weeks, the mice were sacrificed by CO2 overdose and the
scaffolds were excised within their surrounding tissues. The

Statistical analyses were performed using linear mixed effects
models and multiple comparisons were corrected as described
by Hothorn et al. (2008). Statistical analyses were performed
with R statistics software (R Core Team, 2017) using the
“lme4” package for linear and non-linear mixed effects
models (Bates et al., 2015), and the “multcomp” package for
simultaneous inference in general parametric models (Hothorn
et al., 2008). For in vitro immunofluorescence studies, sample
location (peripheral/central) and treatment (static/dynamic)
were included as fixed effects, and ASC donor was included as
a random effect. For the Luminex assay, treatment was included
as a fixed effect and ASC donor was included as a random effect.
For analyses of in vivo samples, treatment and time were included

Immunohistochemical Analysis of Host
Cell Recruitment
Immunostaining was performed to assess host cell infiltration
into the scaffolds at 1, 4, and 8 weeks. More specifically,
CD31 staining was performed to examine host endothelial cell
recruitment. In addition, co-staining was performed for CD26,
a marker that has been associated with highly proliferative
multipotent progenitors that give rise to preadipocytes in murine
subcutaneous adipose tissue (Merrick et al., 2019), along with
the human cell marker Ku80 (Allard et al., 2014), to distinguish
the host-derived CD26+ population. Finally, host immune cell
recruitment was characterized through triple staining for the
pan-leukocyte marker CD45, the murine macrophage marker
F4/80, and the phagocytic macrophage marker CD68. The
phenotype of the infiltrating macrophages was also probed by
co-staining for CD45 in combination with the pro-regenerative
macrophage marker CD163. For each explanted scaffold that was
analyzed (N = 6 for CD31, CD26 and CD163 analyses, N = 4
for macrophage recruitment), three non-adjacent cross-sections
at least 100 µm apart were assessed. Immunohistochemical
staining and imaging were performed following the methods
described above and using the antibodies summarized in Table 2.
Quantification was performed within 10 randomly selected and
non-overlapping, non-adjacent fields of view in each section as
previously described.

R

R

R

R
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TABLE 2 | Primary and secondary antibodies and dilutions used for immunostaining in the in vivo study.
Primary antibody

Primary Dilution

Secondary antibody

Secondary Dilution

CD31 (Abcam ab28364)

1:100

Goat anti-rabbit Alexa R 594
(Abcam ab150080)

1:200

Ku80 (Cell Signaling 2180)

1:200

Goat anti-rabbit Alexa R 594
(Abcam ab150080)

1:400

CD26 (R&D AF954)

1:50

Donkey anti-goat Alexa R 680
(ThermoFisher A-21084)

1:100

CD45 (R&D AF114)

1:100

Donkey anti-goat Alexa R 680
(ThermoFisher A-21084)

1:200

CD68 (BioRad MCA1957)

1:100

Goat anti-rat Alexa R 488
(ThermoFisher A-11006)

1:200

F4/80 (Abcam ab111101)

1:50

Goat anti-rabbit Alexa R 594
(Abcam ab150080)

1:100

CD163 (Abcam ab182422)

1:200

Goat anti-rabbit Alexa R 594
(Abcam ab150080)

1:400

population relative to the total DAPI+ cell population confirmed
that a significantly higher percentage of the ASCs co-expressed
iNOS and Arg-1 within the peripheral region in the dynamic
group (30.9 ± 7.3%) as compared to the peripheral region of the
static group (13.6 ± 6.8%) and the central region of the dynamic
group (14.0 ± 1.6%) (Figure 1C), suggesting that culturing within
the perfusion bioreactor altered the phenotype of the ASCs within
the scaffold periphery.
Further probing the numbers of cells expressing the
individual markers, the density of iNOS+ DAPI+ cells was
significantly higher in the peripheral region of the dynamic group
(122 ± 2 cells/mm2 ) as compared to the peripheral region of
the static group (22 ± 16 cells/mm2 ) and the central region
of the dynamic group (32 ± 8 cells/mm2 ) (Supplementary
Figure 2A). When assessed relative to the total DAPI+ cell
population, the percentage of iNOS+ DAPI+ cells was highest in
the peripheral region of the dynamic group (33.2 ± 7.5%), and
significantly greater than both the central region of the dynamic
group (16.6 ± 0.8%) and the peripheral region of the static
group (14.5 ± 7.4%) (Supplementary Figure 2B). A significantly
higher density of Arg-1+ DAPI+ cells was also observed in the
peripheral region of the dynamic group (306 ± 68 cells/mm2 ) as
compared to the peripheral region of the static group (117 ± 38
cells/mm2 ) and the central region of the dynamic group
(146 ± 51 cells/mm2 ) (Supplementary Figure 2C). However,
when evaluated relative to the total DAPI+ population, there were
no significant differences between the regions or groups, with a
high percentage (>70%) of the ASCs expressing Arg-1 under all
conditions (Supplementary Figure 2D).

as fixed effects, and ASC donor and mouse were included as
random effects. Corrected p-values <0.05 were considered to be
statistically significant. Graphs were produced using GraphPad
Prism version 6 (GraphPad, La Jolla, CA, United States). Error
bars represent the standard deviation.

RESULTS
Dynamic Culture Increased the
Percentage of ASCs Expressing iNOS
Within the Peripheral Regions of the DAT
Scaffolds
Immunostaining was performed to assess the expression of
iNOS and Arg-1 in the ASCs that were cultured statically or
dynamically on the DAT scaffolds for 14 days. A high density
of iNOS+ cells was visualized along the peripheral edges of
the scaffolds in the dynamic group, while Arg-1+ cells were
distributed throughout the scaffolds in both groups (Figure 1A).
Consistent with our previous findings that dynamic culture
within the bioreactor under 2% O2 promoted ASC expansion
within the periphery of the DAT (Han and Flynn, 2020), DAPI
quantification confirmed that the ASC density was significantly
higher in the peripheral region (<200 µm from scaffold edge)
of the dynamic group (562 ± 116 cells/mm2 ), as compared to
the central region (>200 µm from scaffold edge) of the dynamic
group (213 ± 54 cells/mm2 ) and the peripheral region of the
static group (284 ± 80 cells/mm2 ) (Supplementary Figure 1).
Quantification of iNOS+ Arg-1+ DAPI+ cells in the peripheral
and central regions of the scaffolds was performed. A significantly
higher density of iNOS+ Arg 1+ DAPI+ cells was observed in the
peripheral region of the dynamic group (114 ± 5 cells/mm2 )
as compared to the peripheral region of the static group
(18 ± 13 cells/mm2 ) and the central region of the dynamic group
(27 ± 10 cells/mm2 ) (Figure 1B). The data was also analyzed as
a percentage to account for differences in the total cell density in
the two regions for each of the groups, and assess whether there
was significant upregulation in the relative levels of positive cells
with media perfusion. Analysis of the iNOS+ Arg-1+ DAPI+ cell
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Dynamic Culture Increased the Density
of ASCs Expressing TNF-α and IL-10 in
the DAT Scaffolds at 14 Days
Immunostaining was performed for Arg-1 in combination
with TNF-α and IL-10 to determine whether dynamic culture
modulated the abundance and distribution of ASCs expressing
these cytokines. High densities of Arg-1+ , TNF-α+ , and IL-10+
cells were observed within the peripheral regions of the DAT
scaffolds in the dynamic group (Figure 2A). Quantification of the
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FIGURE 1 | Dynamic culture within the perfusion bioreactor for 14 days increased the percentage of human ASCs co-expressing iNOS and Arg-1 within the
peripheral region of the DAT scaffolds. (A) Representative immunostaining for Arg-1 (green) and iNOS (red) with DAPI (blue) for the static and dynamic groups at
14 days. Dashed lines indicate the edge of the DAT scaffolds. Scale bars represent 100 µm. Boxed regions in the composite images are shown at higher
magnification below. White arrowheads highlight Arg-1+ iNOS+ DAPI+ cells. (B) The density of iNOS+ Arg-1+ DAPI+ cells and (C) the percentage of
iNOS+ Arg-1+ DAPI+ cells relative to the total DAPI+ cell population in the central (>200 µm from scaffold edge) and peripheral (<200 µm from scaffold edge)
regions of the DAT scaffolds cultured statically or dynamically. **p < 0.01, ***p < 0.001.

TNF-α+ DAPI+ cells in the peripheral (<200 µm from scaffold
edge) and central (>200 µm from scaffold edge) scaffold regions
revealed a significantly greater density of positive cells in the
peripheral region of the dynamic group (154 ± 23 cells/mm2 )
as compared to the peripheral region of the static group
(46 ± 11 cells/mm2 ) and the central region of the dynamic
group (72 ± 12 cells/mm2 ) (Figure 2B). In addition, the TNFα+ DAPI+ cell density was significantly greater in the central
region of the dynamic group as compared to the central region

Frontiers in Bioengineering and Biotechnology | www.frontiersin.org

of the static group (17 ± 1 cells/mm2 ). When expressed as a
percentage of the total DAPI+ cell population, a significantly
higher percentage of cells were TNF-α+ in the peripheral region
of the dynamic group (46.6 ± 10.9%) as compared to the static
group (25.7 ± 7.9%) (Figure 2C).
Similarly, there were significantly more IL-10+ cells in the
peripheral region of the dynamic group (121 ± 20 cells/mm2 )
as compared to the peripheral region of the static group
(39 ± 12 cells/mm2 ) and the central region of the dynamic
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FIGURE 2 | Dynamic culture within the perfusion bioreactor for 14 days increased the percentage of human ASCs expressing TNF-α+ and IL-10+ in the peripheral
region of the DAT scaffolds. (A) Representative immunostaining showing Arg-1 (green), TNF-α (red), and IL-10 (cyan) expression with DAPI counterstaining (blue) for
the static and dynamic groups. Dashed lines indicate the edge of the DAT scaffolds. Scale bars represent 100 µm. Boxed regions in the composite images are
shown at higher magnification below. White arrowheads highlight Arg-1+ TNF-α+ IL-10+ DAPI+ cells. In the central (>200 µm from scaffold edge) and peripheral
(<200 µm from scaffold edge) regions of the DAT scaffolds in the static and dynamic groups: (B) The TNF-α+ DAPI+ cell density and (C) Percentage of cells
expressing TNF-α. (D) The IL-10+ DAPI+ cell density and (E) Percentage of cells expressing IL-10. (F) The Arg-1+ TNF-α+ IL-10+ DAPI+ cell density and (G)
Percentage of cells co-expressing Arg-1, TNF-α and IL-10. *p < 0.05, **p < 0.01, ***p < 0.001.

(18 ± 8 cells/mm2 ) and the central region of the dynamic
group (36 ± 11 cells/mm2 ) (Figure 2F). Furthermore, a
significantly higher percentage of the DAPI+ cells were TNFα+ IL-10+ (29.8 ± 11.3%) (Supplementary Figure 3) and
Arg-1+ TNF-α+ IL-10+ (28.7 ± 10.9%) (Figure 2G) in the
peripheral regions of the DAT scaffolds in the dynamic
group as compared to the static group (11.2 ± 6.1% and
10.0 ± 4.7%, respectively). Taken together, these findings suggest
that culturing in the perfusion bioreactor increased the fraction
of ASCs that were expressing both TNF-α and IL-10 in the

group (52 ± 8 cells/mm2 ), which was significantly greater than
the central region of the static group (11 ± 1 cells/mm2 )
(Figure 2D). When analyzed as a percentage, a significantly
higher percentage of cells in the peripheral region were IL-10+ in
the dynamic group (36.7 ± 9.7%) as compared to the static group
(21.8 ± 8.2%) (Figure 2E).
Quantification also indicated that the Arg-1+ TNF-α+ IL10+ DAPI+ cell density was significantly higher in the peripheral
region of the dynamic group (95 ± 27 cells/mm2 ) as
compared to the peripheral region of the static group
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FIGURE 3 | Dynamic culture within the perfusion bioreactor altered the paracrine factor expression profile of the human ASCs cultured on the DAT scaffolds for
14 days. Expression of (A) IL-10, (B) CXCL-10, (C) HGF, (D) IL-6, (E) TNF-α, and (F) CXCL-2 as measured by Human Magnetic Luminex R Assay normalized to total
dsDNA content. *p < 0.05.

the importance of angiogenesis in adipose tissue regeneration
(Laschke et al., 2006), the initial characterization focused on
assessing the presence and distribution of CD31+ endothelial
cells within the implants (Figure 4A). Quantification of the
staining confirmed that the CD31+ cell density was significantly
greater in the dynamic group as compared to the static
group at 1- (46 ± 9 cells/mm2 versus 10 ± 9 cells/mm2 ),
4- (67 ± 23 cells/mm2 versus 30 ± 15 cells/mm2 ), and
8-weeks (63 ± 16 cells/mm2 versus 20 ± 6 cells/mm2 )
post-implantation (Figure 4B), supporting that bioreactor
preconditioning enhanced angiogenesis within the implants.

periphery of the DAT, and that the majority of these cells were
also Arg-1+ .

Dynamic Culture Altered the Paracrine
Factor Expression Profile of the ASCs in
the DAT Scaffolds
To further probe whether bioreactor preconditioning altered
the expression levels of some key immunomodulatory factors
expressed within adipose tissue, a custom Luminex assay was
performed. Protein expression levels of IL-10, CXCL-10, HGF, IL6, TNF-α, and CXCL-2 were assessed in lysates prepared from
the ASC-seeded DAT in the static and dynamic groups after
14 days of culture. After normalizing to total dsDNA content,
the protein expression levels of IL-10, CXCL-10, and HGF were
significantly higher, and IL-6 expression was significantly lower,
in the dynamic group as compared to the static group (Figure 3).
No significant differences were observed between the groups in
the protein expression levels of TNF-α or CXCL-2.
R

Dynamic Culture of ASCs on the DAT
Scaffolds Enhanced the Recruitment of
CD26+ Host Cells at 1-Week
Post-implantation in the nu/nu Mouse
Model
Co-staining was performed for CD26 and for human-specific
Ku80 (Figure 5A and Supplementary Figure 5) to probe host
CD26+ cell infiltration into the implants at 1, 4, and 8 weeks postimplantation, as a potential marker of multipotent progenitor
cells that can give rise to preadipocytes and adipocytes (Merrick
et al., 2019). Quantification of the CD26+ Ku80− DAPI+ cell
population indicated that there was a significantly higher density
of CD26+ host cells in the DAT implants within the dynamic
group at 1-week post-implantation (142 ± 81 cells/mm2 ) as
compared to the static group (53 ± 49 cells/mm2 ), as well as
the dynamic group at both 4- (56 ± 30 cells/mm2 ) and 8-weeks
(35 ± 15 cells/mm2 ) post-implantation (Figure 5B).

Dynamic Culture of ASCs on the DAT
Enhanced CD31+ Endothelial Cell
Recruitment Into the Scaffolds Following
Implantation in the nu/nu Mouse Model
Following in vitro characterization, in vivo studies were
performed to probe how bioreactor preconditioning modulated
the capacity of the ASC-seeded DAT to stimulate the recruitment
of a range of host cell populations at 1-, 4-, and 8-weeks postimplantation, which may have contributed to the markedly
enhanced adipose tissue regeneration previously reported in this
group (Supplementary Figure 4; Han and Flynn, 2020). Given
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post-implantation (Supplementary Figure 6). No significant
differences were observed in the Ku80+ DAPI+ cell density
between the static and dynamic groups at 4 or 8 weeks.
However, there was substantial variability in the dynamic group
at 8 weeks, with fewer human cells present in the implants that
had undergone more substantial remodeling into adipose tissue.

Dynamic Culture of ASCs on the DAT
Scaffolds Did Not Alter Host
Macrophage Recruitment Following
Implantation in the nu/nu Mouse Model
To probe host macrophage infiltration into the DAT implants
over time, immunostaining was performed for mouse CD45
as a pan-leukocyte marker in combination with F4/80 as a
marker of mature mouse macrophages, and CD68 as a marker of
phagocytic macrophages. Qualitatively, high densities of CD45+ ,
F4/80+ and CD68+ cells were observed within the DAT implants
in both groups at 1- (Figure 6A), 4- (Supplementary Figure 7),
and 8-weeks (Supplementary Figure 8) post-implantation.
Quantification of the CD45+ F4/80+ CD68+ DAPI+ cells
indicated there was a significantly higher density in the dynamic
group at 1-week post-implantation (596 ± 187 cells/mm2 )
as compared to both 4- (310 ± 97 cells/mm2 ) and 8-weeks
(249 ± 86 cells/mm2 ) (Figure 6B). However, no significant
differences were observed between the dynamic and static groups
at any of the timepoints.
Analysis of the percentage of CD45+ cells that co-expressed
both F4/80 and CD68 within the total CD45+ DAPI+ cell
population in the DAT implants indicated that the majority
(∼95%) of the CD45+ cells were F4/80+ CD68+ at 1 and
4 weeks, but a significant decline in this subpopulation was
observed within both groups at 8 weeks, with (80.8 ± 6.1%)
and (81.3 ± 3.5%) of the CD45+ population co-expressing
F4/80+ CD68+ in the dynamic and static groups respectively
(Figure 6C). Individual analysis of the CD45+ F4/80+ DAPI+
(Supplementary Figure 9A) and CD45+ CD68+ DAPI+
(Supplementary Figure 9B) populations as a percentage of the
total CD45+ DAPI+ population within the implants confirmed
that a high percentage (>90%) of the CD45+ population
expressed these macrophage markers at 1 and 4 weeks. However,
a similar significant decline in the relative expression levels of
both individual markers was observed at 8 weeks.

FIGURE 4 | Dynamic culture of ASCs on the DAT scaffolds enhanced CD31+
cell recruitment following implantation in the nu/nu mouse model.
(A) Representative immunostaining showing CD31 (red) with DAPI
counterstaining (blue) within the DAT implants for both the static and dynamic
groups at 1-, 4- and 8-weeks post-implantation. Scale bars represent
100 µm. Boxed regions in the 8-week images are shown at higher
magnification below. (B) CD31+ DAPI+ endothelial cell density in the implants.
***p < 0.001.

Dynamic Culture of the Human ASCs on
the DAT Scaffolds Prior to Implantation
Modulated Macrophage Phenotype
Within the Implants in the nu/nu Mouse
Model
To probe the macrophage phenotype within the implants,
co-staining was performed for the pan-leukocyte marker
CD45 with the pro-regenerative macrophage marker CD163
(Figure 7A). Interestingly, while CD45+ cells were observed
infiltrating the implants at 1, 4, and 8 weeks, a relatively
small number of CD45+ CD163+ cells were visualized within
the scaffolds, with the exception of the dynamic group at

Quantification of the Ku80+ DAPI+ human ASC population
was also performed. The Ku80+ DAPI+ cell density was
significantly higher in the dynamic group relative to the static
group at 1-week post-implantation (196 ± 44 cells/mm2 versus
69 ± 18 cells/mm2 ), as well as the dynamic group at both
4- (81 ± 43 cells/mm2 ) and 8-weeks (62 ± 76 cells/mm2 )
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FIGURE 5 | Dynamic culture of human ASCs on the DAT scaffolds enhanced the recruitment of CD26+ host cells at 1-week post-implantation in the nu/nu mouse
model. (A) Representative immunostaining of CD26 (green) in combination with human-specific Ku80 (red), with DAPI counterstaining (blue) at 1-week
post-implantation. Scale bars represent 50 µm. Boxed regions are shown at higher magnification below. Arrows indicate CD26+ Ku80- DAPI+ mouse cells and
arrowheads highlight CD26+ Ku80+ DAPI+ human cells. (B) CD26+ host cell (CD26+ Ku80- DAPI+ ) density within the DAT implants at 1, 4, and 8 weeks. **p < 0.01,
***p < 0.001.

cell population, a significantly higher fraction of the CD45+
cells were CD163+ in the dynamic group as compared to
the static group at 1 (17.8 ± 3.8% versus 8.9 ± 1.8%), 4
(27.9 ± 7.3% versus 21.8 ± 5.3%) and 8 (47.3 ± 6.5% versus
22.2 ± 7.4%) weeks, with significantly higher levels observed for
the dynamic group at 8-weeks post-implantation as compared to
both earlier timepoints (Figure 7C), supporting that bioreactor
preconditioning promoted a more pro-regenerative macrophage
phenotype within the implants over time.

8 weeks. The density of CD45+ CD163+ DAPI+ cells was
quantified within the implanted scaffolds, excluding the fibrous
capsule. The analysis confirmed that there were significantly
more CD45+ CD163+ DAPI+ cells within the DAT implants
in the dynamic group at 8 weeks (131 ± 31 cells/mm2 )
relative to the static group at 8 weeks (45 ± 12 cells/mm2 ),
as well as the dynamic group at 1 (35 ± 11 cells/mm2 ) and
4 (63 ± 18 cells/mm2 ) weeks post-implantation (Figure 7B).
When expressed as a percentage of the total CD45+ DAPI+
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FIGURE 6 | The recruitment of CD45+ F4/80+ CD68+ macrophages was similar in the ASC-seeded DAT scaffolds that were cultured dynamically and statically for
14 days prior to implantation in the nu/nu mouse model. (A) Representative images showing CD45 (cyan), F4/80 (red), and CD68 (green) expression with DAPI
counterstaining (blue) at 1-week post-implantation. Scale bars represent 100 µm. Boxed regions in the composite images are shown at higher magnification below.
White arrowheads highlight CD45+ F4/80+ CD68+ DAPI+ cells. (B) CD45+ F4/80+ CD68+ DAPI+ cell density in the static and dynamic groups. (C) The percentage of
CD45+ F4/80+ CD68+ DAPI+ cells relative to the total CD45+ DAPI+ cell population at 1, 4, and 8 weeks. *p < 0.05, **p < 0.01, ***p < 0.001.

promote cell expansion and markedly enhance angiogenesis and
host adipogenesis following subcutaneous implantation in the
nu/nu mouse model (Han and Flynn, 2020). The in vivo effects
were likely attributed in part to the delivery of a significantly

DISCUSSION
Culturing human ASCs on DAT scaffolds within the perfusion
bioreactor under 2% O2 over 14 days was previously shown to
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FIGURE 7 | Dynamic culture of human ASCs on the DAT scaffolds enhanced the percentage of cells expressing the pro-regenerative macrophage marker CD163 in
the CD45+ host cell population at 8 weeks post-implantation in the nu/nu mouse model. (A) Representative images showing CD45 (green), CD163 (red), and DAPI
(blue). Dashed lines indicate the border between the fibrous capsule (top) and the DAT implant (bottom). Scale bars represent 100 µm. Boxed regions in the
8-week images are shown at higher magnification below. White arrowheads highlight CD45+ CD163+ cells. (B) CD45+ CD163+ DAPI+ cell density within the DAT
implants. (C) The percentage of CD45+ CD163+ DAPI+ cells relative to the total CD45+ DAPI+ population. *p < 0.05, **p < 0.01, ***p < 0.001.
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such as TNF-α was sufficient to initiate a regenerative response
but not shift the overall microenvironment toward a more proinflammatory state that may not be conducive for regeneration.
To further assess whether culturing within the bioreactor
modulated the paracrine profile of the ASCs on the DAT, a
multiplex Luminex assay was performed to characterize the
overall expression levels of a range of immunomodulatory factors
expressed within adipose tissue. IL-10 expression, which has
been shown to promote a more pro-regenerative macrophage
phenotype (Mocellin et al., 2003; Boehler et al., 2014) and
downregulate the expression of pro-inflammatory cytokines in
immune cell populations (Peranteau et al., 2008; MartínezChaæon et al., 2018), was significantly enhanced in the dynamic
group. In addition, the macrophage chemoattractant CXCL-10
(Petrovic-Djergovic et al., 2015), as well as the pro-angiogenic
and anti-inflammatory factor HGF (Beilmann et al., 2004;
Ceccarelli et al., 2020), were also detected at significantly
higher levels in the lysates from the dynamic group. HGF can
regulate endothelial cell survival, proliferation and migration
(Kawaguchi and Kataoka, 2014), as well as endothelial tube
formation (Beilmann et al., 2004). As such, the enhanced
expression of this factor may have played a role in the
increased CD31+ cell recruitment observed in the in vivo model.
Further, HGF has also been shown to have immunomodulatory
effects on monocytes and macrophages, promoting a more
pro-regenerative response (Chen et al., 2014; Choi et al.,
2019). The expression of IL-6, which is known to promote
the pro-inflammatory polarization of monocytes (Mori et al.,
2011; Scheller et al., 2014), was significantly downregulated in
the dynamic group. However, no significant differences were
observed in the overall protein expression levels of the proinflammatory factors TNF-α and CXCL-2 within the lysates
between the static and dynamic groups, supporting that the
enhanced TNF-α expression observed in the IHC studies was
highly localized.
It is possible that shear stress stimulation induced by
media perfusion within the bioreactor may have altered
the ASC phenotype and secretory profile. Shear forces can
activate mechanosignaling pathways, including the MAPK and
JNK pathways, through integrin activation, tensegrity-mediated
mechanosensing, and by inducing changes in the fluidity of
the cell membrane (Stolberg and McCloskey, 2009). Human
ASCs have also been shown to possess a primary cilium
(Hilgendorf et al., 2019), which has the potential to function
as a shear stress sensor and signal transducer. Most studies
to date exploring biomechanical stimulation on MSCs have
focused on differentiation, rather than on possible effects
on pro-angiogenic or immunomodulatory capacities. However,
mechanical stimulation through intermittent fluid flow has
previously been reported to increase the production of a range
of pro-angiogenic and immunomodulatory factors including
VEGFA, HGF, G-CSF, and IL-8 in cultured human ASCs (Bravo
et al., 2017). Similarly, Becquart et al. (2016) demonstrated that
intermittent shear stress stimulated the production of nitric
oxide (NO) and enhanced mRNA expression of VEGFA, FGF2,
and IGF1 in cultured human bone marrow-derived MSCs. In
addition, Lee et al. (2017) recently demonstrated that human

larger dose of ASCs in the bioreactor cultured scaffolds relative
to the statically cultured controls. However, there is evidence to
support that culturing under shear stress can induce functional
changes in MSC populations that may influence their capacity
to stimulate regeneration (Bassaneze et al., 2010; Yuan et al.,
2013; Becquart et al., 2016). As such, the current study sought
to explore whether the phenotype and paracrine function of the
ASCs on the DAT were altered by preconditioning the scaffolds
within the bioreactor.
Inducible nitric oxide synthase and Arg-1 are enzymes
involved in distinct pathways of arginine catabolism that have
been commonly employed as functional markers of M1 and
M2 macrophage polarization, respectively (Rath et al., 2014). In
addition, previous studies have shown that iNOS expression is
critical for the pro-regenerative immunomodulatory function of
murine MSC populations (Ren et al., 2008; Li et al., 2012; Maria
et al., 2018). Interestingly, iNOS expression was significantly
enhanced in the human ASCs within the peripheral region of
the DAT scaffolds in the dynamic group. Further, there was a
significantly higher fraction of ASCs that co-expressed iNOS and
Arg-1 in the peripheral region of the dynamic group, suggesting
that bioreactor preconditioning modulated the ASC phenotype
in the periphery of the DAT. In general, Arg-1 was found to
be expressed by a high percentage of the ASCs cultured on the
DAT scaffolds, which to the best of our knowledge, has not
been explored as an MSC marker. However, a previous study
reported that an isolated human CD90+ CD45− intraperitoneal
cell population expressed high levels of Arg-1 and suppressed
T-cell proliferation in culture, with the immunomodulatory
effects regulated by the L-arginine concentration (Rath et al.,
2014). While further investigation into the functional role of Arg1 in human ASCs is warranted, it is possible that the observed
expression may be associated with the known anti-inflammatory
capacity of these cells (Ceccarelli et al., 2020).
The immunohistochemical analyses also demonstrated that a
significantly higher fraction of the ASCs in the peripheral region
of the DAT scaffolds in the dynamic group expressed TNF-α and
IL-10, suggesting that bioreactor preconditioning promoted the
localized production of these factors, which may have modulated
the response of infiltrating host cell populations. Although
TNF-α and other pro-inflammatory factors are often regarded
negatively for their association with chronic inflammation and
disease (Bulló et al., 2003; Maachi et al., 2004), it is becoming
increasingly recognized that inflammation plays an important
role in stimulating angiogenesis and tissue regeneration (Sainson
et al., 2008; Kwon et al., 2013). It is important to note that
the staining patterns demonstrating higher numbers of cells
expressing the markers within the peripheral regions of the DAT
(<200 µm from scaffold edge) suggest that media perfusion into
the interior of the scaffolds was likely restricted over time within
the bioreactor, which we also reported in our previous study
(Han and Flynn, 2020). Despite this limitation, the perfusion
bioreactor approach was effective at markedly enhancing in vivo
adipose tissue regeneration within the DAT. While having a
more homogeneous population of “activated” ASCs throughout
the scaffold could potentially further augment regeneration, it
is also possible that the locally enhanced expression of factors
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for CD45, F4/80, and CD68, which showed no significant
differences in terms of cell densities between the groups at
any of the timepoints. Similarly, we previously found that
seeding with ASCs modulated macrophage phenotype but
did not specifically alter macrophage recruitment into the
DAT implants in immunocompetent rat and mouse models
(Han et al., 2015; Robb et al., 2020). Notably, there was an
increased percentage of CD45+ cells that were F4/80− and
CD68− within both implant groups at 8 weeks. These cells
may be other myeloid cell populations or their precursors,
or potentially T cells (Kennedy et al., 1992) or natural killer
cells (Krzywinska et al., 2016). It would be interesting to more
fully characterize these cells to better understand their potential
effects within the implants in future studies, including additional
markers with quantitative analysis of digested explants using
multicolor flow cytometry.
While there was no difference in total macrophage
recruitment, analysis of CD163 expression in the CD45+
cell population suggested that dynamic preconditioning of
the ASCs on the DAT ultimately led to a shift toward a more
pro-regenerative macrophage phenotype. In particular, CD163+
macrophages have been associated with both angiogenesis
and ECM remodeling in implanted biomaterials (Spiller et al.,
2014). The increased presence of CD163+ macrophages within
the dynamically cultured implants is similar to our previous
findings on the effects of ASC seeding in the immunocompetent
rat and mouse models (Han et al., 2015; Robb et al., 2020),
and these cells may have contributed to the enhanced
remodeling of the DAT into host-derived adipose tissue
(Han and Flynn, 2020).
Based on the in vitro and in vivo data in the current
study, we postulate that the markedly enhanced adipose tissue
regeneration observed following implantation of bioreactor
preconditioned DAT scaffolds was due to the combined effects
of (i) the delivery of a larger number of cells and (ii) alterations
in the ASC phenotype and paracrine function within the
periphery of the DAT. Addressing limitations in the current
study, future work should focus on decoupling these effects
and verifying that the ASCs that expressed the markers such
as iNOS did indeed have enhanced pro-angiogenic and/or
immunomodulatory capacities. These studies should include
functional assays, for example, probing specific effects on
endothelial cell proliferation and tubule formation, as well as
macrophage polarization. For follow-up in vivo studies, especially
those focused on characterizing the immunomodulatory effects
of the ASCs, testing in humanized mouse models should be
considered (Mehler et al., 2019). Using these models, it would
be interesting to more fully characterize the phenotype of the
infiltrating macrophages over time, and assess the role of other
immune cell populations including T-cells. It would also be
beneficial to perform studies using human ASCs engineered to
stably express luciferase to enable more accurate tracking of
the viable cells within the living animals through longitudinal
bioluminescence imaging.
Although preconditioning the cells within the 3-D perfusion
bioreactor system on the same scaffold on which they were
delivered was effective within our pre-clinical model, it

bone marrow-derived MSCs cultured under physiological shear
stress within a microfluidic system showed enhanced antiinflammatory function, with the effects regulated through focal
adhesion kinase (FAK) signaling.
Notably, in addition to shear stress other factors could have
contributed to the altered protein expression levels observed
between the groups in the current study, including differences
in the cell density, variations in the local concentration of
nutrients, oxygen or other metabolites, as well as a cascading
effect of other growth factors or cytokines. For example, in
lipopolysaccharide (LPS)-induced macrophages in vitro and
in interstitial macrophages in C57BL/6J mice, the enhanced
expression of HGF was found to decrease IL-6 and increase IL10 expression (Kamimoto et al., 2009). Further studies using
alternative bioreactor platforms would be required to more
specifically assess the effects of fluid shear stress on the proangiogenic and immunomodulatory functionality of the ASCs.
Building from the in vitro data, in vivo studies were performed
to assess the effects of bioreactor preconditioning on host cell
recruitment. Consistent with our previous findings that there was
a significant increase in the density of erythrocyte-containing
blood vessels in the DAT implants in the dynamic group at
4 and 8 weeks (Han and Flynn, 2020), CD31+ endothelial
cell recruitment was significantly enhanced in the dynamic
group at all three timepoints in the current study, suggesting
that culturing within the bioreactor augmented the capacity
of the ASCs to stimulate angiogenesis within the implants.
As it is well-recognized that the induction of angiogenesis is
required for stable adipose tissue formation within engineered
bioscaffolds (Ceccarelli et al., 2020), this may have contributed
to the increased adipogenesis observed within this group
(Han and Flynn, 2020).
The infiltration of host-derived CD26+ cells was probed
as a marker that has been associated with an adipocyte
precursor phenotype. More specifically, Merrick et al. (2019)
demonstrated that a CD26+ interstitial progenitor population
within murine adipose tissue could give rise to an intermediate
population that was committed to the adipogenic lineage
and could differentiate into mature adipocytes in vivo. The
higher density of host-derived CD26+ cells observed at 1 week
post-implantation in the dynamic group, combined with the
previously characterized adipo-inductive effects of this group
(Han and Flynn, 2020), suggests that the dynamically cultured
DAT scaffolds have the potential to both recruit progenitors and
drive their differentiation toward an adipogenic state, associated
with downregulation of CD26 expression (Merrick et al., 2019).
However, it should be noted that other cell types can express
CD26, including dendritic cells (Gliddon and Howard, 2002;
Zhong et al., 2013), macrophages (Zhong et al., 2013), and natural
killer cells (Bühling et al., 1994), and future studies should more
fully characterize the CD26+ population and its involvement in
adipogenesis within the DAT.
Macrophages have been indicated to play an important role
in mediating both angiogenesis and adipose tissue regeneration
within ECM-derived bioscaffolds (Debels et al., 2013; Han
et al., 2015). As such, the effects of dynamic culture on
host macrophage recruitment were probed through co-staining

Frontiers in Bioengineering and Biotechnology | www.frontiersin.org

14

March 2021 | Volume 9 | Article 642465

Han et al.

Bioreactor Preconditioning of ASCs on DAT

may be worthwhile to consider separate platforms for cell
preconditioning versus cell delivery as a potentially more scalable
approach to advance toward future clinical translation as a cellbased therapy for large volume soft tissue augmentation. More
specifically, alternative bioreactor systems could be designed that
combine shear stress stimulation with culturing on ECM-derived
bioscaffolds where the cells could be more uniformly subjected to
the applied forces to avoid the heterogeneity that was observed
in the cellular response in the current study. For example, our
previously established stirred bioreactor system for expanding the
ASCs on DAT microcarriers could hold promise as a dynamic
preconditioning platform (Yu et al., 2017). The preconditioned
cells could subsequently be incorporated within other biomaterial
scaffolds designed to provide structural support and maintain the
volume as host adipose tissue regeneration progresses, such as the
intact DAT scaffolds used in the current study.
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The findings of the current study support that dynamic
preconditioning of human ASCs on the DAT scaffolds within
the perfusion bioreactor under 2% O2 altered their phenotype
and paracrine profile relative to controls cultured under static
conditions. Interestingly, a substantial fraction of the ASCs
within the peripheral region of the DAT implants in the dynamic
group simultaneously expressed iNOS and Arg-1, as well as both
TNF-α and IL-10, suggesting they had a complex phenotype.
Analysis in the in vivo model indicated that culturing within
the bioreactor prior to implantation enhanced the recruitment
of CD31+ endothelial cells, as well as CD26+ host cells,
into the implants, which likely contributed to the increased
angiogenesis and adipogenesis previously reported in this group.
While there was no significant difference in total macrophage
recruitment between the groups, greater infiltration of CD163+
macrophages was observed in the dynamic group, indicative of
a shift toward a more pro-regenerative macrophage response
favorable for implant remodeling. Taken together with our
previous work, the in vitro and in vivo findings suggest that
bioreactor preconditioning can augment the capacity of human
ASCs to stimulate adipose tissue regeneration within the DAT,
and that these effects are likely mediated by a combination of
increased expansion resulting in the delivery of a larger number
of ASCs, as well as alterations in the paracrine functionality of the
delivered ASCs. Overall, the current study supports the further
investigation of dynamic culture under shear stress as a means to
precondition ASCs and enhance their capacity to stimulate tissue
regeneration through paracrine-mediated mechanisms.
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